Stock Report

Neuland Laboratories Ltd consolidated Q2 FY2023 PAT jumps to Rs. 38.45 crores

Posted On : 2022-11-11 14:03:23( TIMEZONE : IST )

Neuland Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2022.

Financial Results (Q2 FY2023) - QoQ Comparison

The company has reported total income of Rs. 293.9446 crores during the period ended September 30, 2022 as compared to Rs. 221.6817 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs. 38.4597 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. 9.9658 crores for the period ended June 30, 2022.

The company has reported EPS of Rs. 29.97 for the period ended September 30, 2022 as compared to Rs. 7.77 for the period ended June 30, 2022.

Financials	Q2 FY2023	Q1 FY2023	% Change
Total Income	₹ 293.9446 crs	₹221.6817 crs	32.60%
Net Profit	₹38.4597 crs	₹9.9658 crs	285.92%
EPS	₹29.97	₹7.77	285.71%

Financial Results (Q2 FY2023) - YoY Comparison

The company has reported total income of Rs. 293.9446 crores during the period ended September 30, 2022 as compared to Rs.258.1341 crores during the period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.38.4597 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.20.3711 crores for the period ended September 30, 2021.

The company has reported EPS of Rs.29.97 for the period ended September 30, 2022 as compared to Rs.15.88 for the period ended September 30, 2021.

Financials	Q2 FY2023	Q2 FY2022	% Change
Total Income	₹ 293.9446 crs	₹258.1341 crs	13.87%
Net Profit	₹38.4597 crs	₹20.3711 crs	88.80%
EPS	₹29.97	₹15.88	88.73%

Financial Results (Half Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.515.6263 crores during the 6 Months period ended September 30, 2022 as compared to Rs.461.0767 crores during the 6 Months period ended September 30, 2021.

The company has posted net profit / (loss) of Rs.48.4255 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.29.1056 crores for the 6 Months period ended September 30, 2021.

The company has reported EPS of Rs.37.74 for the 6 Months period ended September 30, 2022 as compared to Rs.22.69 for the 6 Months period ended September 30, 2021.

Financials	Half Year Ended FY2023	Half Year Ended FY2022	% Change
Total Income	₹515.6263 crs	₹461.0767 crs	11.83%
Net Profit	₹48.4255 crs	₹29.1056 crs	66.38%
EPS	₹37.74	₹22.69	66.33%

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 1701.80 as compared to the previous close of Rs. 1418.20. The total number of shares traded during the day was 56485 in over 4768 trades.

The stock hit an intraday high of Rs. 1701.80 and intraday low of 1365.00. The net turnover during the day was Rs. 92049899.00.